Value of Robotically Assisted Surgery for Mitral Valve Disease

Authors:

Abstract
Robotically assisted surgery is the least invasive approach for treating myxomatous mitral valve disease. Benefits include less trauma, faster recovery leading to a quicker return to work or normal activities, and superior cosmesis, with comparable success, safety, and effectiveness.1-5 However, the value of this emerging technology for mitral valve repair is questioned because associated incremental costs beyond those of conventional surgery—capital investment, maintenance, and robotic-specific disposable instruments—may outweigh these clinical benefits. The purpose of this study was to investigate the value of robotically assisted surgery for mitral valve repair by assessing whether benefits mitigate the additional cost.6 We compared its cost with those of conventional approaches, including offsets from shorter recovery and earlier return to work or normal activities.

This publication has 33 references indexed in Scilit: